Target: FAP

68Ga-OncoFAP – Various Solid Tumors
Partner: Bracco

Preclinic

Phase I

Phase II

Phase III

8F-OncoFAP –Various Solid Tumors (Imaging)
Partner: Bracco

Preclinic

Phase I

Phase II

Phase III

177Lu-OncoFAP-23 – Various Solid Tumors (Therapy)

Preclinic

Phase I

Phase II

Phase III

OncoFAP–GlyPro-MMAE – Various Solid Tumors (Therapy)

Preclinic

Phase I

Phase II

Phase III

Target: ACP3

68Ga-OncoFAP – Various Solid Tumors

Preclinic

Phase I

Phase II

Phase II

18F-OncoACP3 – Prostate Cancer (Imaging)

Preclinic

Phase I

Phase II

Phase III

255Ac-OncoACP3 – Prostate Cancer (Therapy)

Preclinic

Phase I

Phase II

Phase III

177Lu-OncoACP3 – Prostate Cancer (Therapy)

Preclinic

Phase I

Phase II

Phase III

Target: CAIX

68Ga-OncoCAIX – Renal Cell Carcinoma (Imaging)

Preclinic

Phase I

Phase II

Phase II

177Lu-OncoCAIX – Renal Cell Carcinoma (Therapy)

Preclinic

Phase I

Phase II

Phase III

Philochem builds the chemical pipeline of the Philogen group. For the complete pipeline of the Philogen group see www.philogen.com